ADENOVIRUS - ANVISA Registration 10259610134

Access comprehensive regulatory information for ADENOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610134 and manufactured by SIEMENS HEALTHCARE DIAGNOSITCS INC.. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including R-BIOPHARM AG, NOVATEC IMMUNDIAGNOSTICA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10259610134
Registration Details
ANVISA Registration Number: 10259610134
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Adenovirus 5’ Hexon primer pair
Risk Class II

Registration Details

10259610134

25351658185201115

68814961000173

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jan 30, 2012

VIGENTE

09/18/2025 19:00:01